Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENUFLEX
2013-005088-13Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in hemiparesis, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hemiparesis
Beyond the preview
Go deeper on 2013-005088-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005088-13.